C
Colleen A. McHorney
Researcher at Merck & Co.
Publications - 94
Citations - 26694
Colleen A. McHorney is an academic researcher from Merck & Co.. The author has contributed to research in topics: Health care & Item response theory. The author has an hindex of 46, co-authored 94 publications receiving 25191 citations. Previous affiliations of Colleen A. McHorney include Medical College of Wisconsin & University of Wisconsin-Madison.
Papers
More filters
Journal ArticleDOI
Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: A prospective analysis of data from pharmacy claims
TL;DR: In the present analysis of the validity of the Adherence Estimator in predicting adherence, baseline propensity to adhere to medications prescribed for chronic diseases was statistically associated with several measures of adherence and persistence, as derived from pharmacy claims data, over a 9-month period.
Journal ArticleDOI
CONNECT: a measure of continuity of care in mental health services.
TL;DR: The results of a field test in which 400 persons with serious mental illness completed CONNECT indicate that the measure is easily administered and produces well-distributed responses, which indicate fair- to-good agreement.
Journal ArticleDOI
Exploring the implementation of patient-reported outcome measures in cancer care: need for more real-world evidence results in the peer reviewed literature
Milena D. Anatchkova,Sarah Donelson,Anne Skalicky,Colleen A. McHorney,Dayo Jagun,Jennifer Whiteley +5 more
TL;DR: Before the promise of practice-based PRO assessment in oncology can be truly realized, investigators need to advance the state-of-the-art of real-time PRO score interpretation as well as developing guidance on how to use PRO insights to drive clinically-meaningful patient-management strategies.
Journal ArticleDOI
Beliefs that influence cost-related medication non-adherence among the "haves" and "have nots" with chronic diseases.
TL;DR: Beyond objective financial measures, CRN is influenced by patient beliefs, which can influence the perceived value of prescription drugs, and addressing these beliefs could decrease CRN rates even if cost pressures themselves cannot be reduced.
Journal ArticleDOI
Development and validation of motivational messages to improve prescription medication adherence for patients with chronic health problems.
Gary L. Kreps,Melinda M. Villagran,Xiaoquan Zhao,Colleen A. McHorney,Christy J.W. Ledford,Melinda Weathers,Brian Keefe +6 more
TL;DR: Experimental research showed that exposure to motivational messages increased consumers' intention to adhere with medication recommendations, and follow-up intervention research is warranted to test the use of these motivational messages to promote medication adherence.